Evidence map›Paper›PMID 39926455›Full record

ArticleSurgical neurology international2025

Pediatric subcutaneous nasal glial heterotopia.

Moajeb Turki Alzahrani, Balgess Abdullah Ajlan, Alaa Samkari, Afnan Mahfouz Samman

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moajeb Turki AlzahraniDepartment of Neuroscience, Section of Neurosurgery, King Abdulaziz Medical City National Guard Health Affairs, Jeddah, Saudi Arabia.
Balgess Abdullah AjlanDepartment of Surgery, Division of Neurosurgery, Dalhousie University, Queen Elizabeth II Health Sciences Centre (Halifax Infirmary), Halifax, Canada.
Alaa SamkariDepartment of Pathology and Laboratory Medicine, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.
Afnan Mahfouz SammanDepartment of Neurosurgery, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nasal glial heterotopias (NGHs) are benign lesions diagnosed at birth that are treated with complete surgical excision and have a low recurrence rate. The impact of the timing of resection on the patients' outcome remains unclear. Case Description: We report a case of pediatric midline subcutaneous extranasal glial heterotopia over the nasal bridge in a 4-day-old female newborn. At the age of 6 months, she underwent a complete surgical excision. Follow-up magnetic resonance imaging at 3 years showed no evidence of recurrence. A summary of the 19 published cases of the specific entity of purely subcutaneous extranasal glial heterotopia among the pediatrics age group in the literature is presented, and the timing of surgery in relation to outcome is discussed. Conclusion: Our review revealed that surgery for NGH can be safely performed when the child is 6-12 months old, and the child should be followed probably until school age.

Indexed as

Nasal cerebral heterotopiaNasal glial heterotopiaNasal gliomaNeuroglial heterotopia

Identifiers

PMID39926455
PMCPMC11799680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.